Actively Recruiting
Prognostic Model of Hypertension
Led by Xinjiang Medical University · Updated on 2024-03-28
50000
Participants Needed
1
Research Sites
521 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of this study was to establish a registration and monitoring system for hypertension in Xinjiang from 2020 to 2030 to obtain real information about patient basic information, patient characteristics, diagnostic test patterns, treatment options, and hospitalization outcomes (including mortality). Treatment complications, hospitalization costs, and end-of-life events (death, major adverse cardiac events, mild adverse cardiovascular events) in patients with hypertension in Xinjiang; and scientific prevention strategies aimed at effectively preventing the onset of hypertension; Guidelines in clinical practice recommend, analyze and develop effective treatment strategies to optimize management and outcomes for patients with hypertension; and create cost-effective assessment systems.
CONDITIONS
Official Title
Prognostic Model of Hypertension
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with primary hypertension
- Admitted to the First Affiliated Hospital of Xinjiang Medical University
You will not qualify if you...
- Patients with secondary hypertension
- Patients with liver and kidney dysfunction
- Patients with mental disorders
- Patients unwilling to participate in this trial
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
The First Affiliated Hospital of Xinjiang Medicial University
Ürümqi, Xinjiang, China, 830000
Actively Recruiting
Research Team
X
Xiang Xie, Phd
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here